TRAIL R4 (Intracellular Domain) Blocking Peptide

TRAIL R4 (Intracellular Domain) Blocking Peptide

Product No.: D266

[product_table name="All Top" skus="D266"]

- -
- -
Target
TNF-Related Apoptosis-Inducing Ligand Receptor 4
Product Type
Blocking Peptide
Alternate Names
TNFRSF10D, Decoy Receptor 2 (DCR2), CD264, TRUNDD, TR4

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Amino Acid Location
This peptide sequence is located at amino acids 249 to 263 of Human DcR2 protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
TNF-related apoptosis-inducing ligand receptor 4 (TRAIL R4) is a decoy receptor that negatively regulate TRAIL-induced cytotoxicity by competing for ligand binding with TRAIL-R1 and TRAIL-R2.1 TRAIL R4 is expressed mainly on CD8+ and NK cells and induces apoptosis in many tumour cells, but not in normal cells. TRAIL-R4 contains partially truncated death domain and therefore is unable to induce apoptosis and serves as a negative regulator of apoptotic signaling by impairment death-inducing signaling complex (DISC) processing.1,2

Antigen Details

References & Citations

1. Chan FK et al. (2005) Proc Natl Acad Sci USA 102: 18099 2. Sanlioglu S et al. (2005) BMC Cancer 5: 54
Products are for research use only. Not for use in diagnostic or therapeutic procedures.